1.12
X T L Biopharmaceuticals Ltd Adr stock is traded at $1.12, with a volume of 66,395.
It is down -6.67% in the last 24 hours and down -10.47% over the past month.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
See More
Previous Close:
$1.20
Open:
$1.2258
24h Volume:
66,395
Relative Volume:
7.24
Market Cap:
$9.70M
Revenue:
-
Net Income/Loss:
$-2.25M
P/E Ratio:
-2.80
EPS:
-0.4
Net Cash Flow:
-
1W Performance:
+1.82%
1M Performance:
-10.47%
6M Performance:
-37.78%
1Y Performance:
-48.51%
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Name
X T L Biopharmaceuticals Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare XTLB with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
XTLB
X T L Biopharmaceuticals Ltd Adr
|
1.12 | 9.70M | 0 | -2.25M | 0 | -0.40 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-08-15 | Initiated | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Latest News
XTL Biopharmaceuticals Announces Shareholder Meeting for Key Decisions - TipRanks
XTL Biopharmaceuticals Appoints Noam Band as CEO - TipRanks
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil - TipRanks
XTL Biopharmaceuticals Adjusts Board Representation Amid Resignations - TipRanks
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
XTL Biopharmaceuticals Expands Portfolio with Social Proxy Acquisition Amidst Regional Challenges - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher - Markets Insider
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):